108 related articles for article (PubMed ID: 37932193)
1. Esophageal cancer: Does inaccuracy in clinical staging affect our ability to reach optimal outcomes?
Swanson J; Roat-Shumway S; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
Surgery; 2024 Feb; 175(2):342-346. PubMed ID: 37932193
[TBL] [Abstract][Full Text] [Related]
2. Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.
Samson P; Puri V; Robinson C; Lockhart C; Carpenter D; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
Ann Thorac Surg; 2016 Jun; 101(6):2102-11. PubMed ID: 27083246
[TBL] [Abstract][Full Text] [Related]
3. Predictors of pathologic upstaging in early esophageal adenocarcinoma: Results from the national cancer database.
Brown CS; Gwilliam N; Kyrillos A; Lutfi W; Lapin B; Kim KW; Krantz SB; Howington JA; Yao K; Ujiki MB
Am J Surg; 2018 Jul; 216(1):124-130. PubMed ID: 28802729
[TBL] [Abstract][Full Text] [Related]
4. Textbook oncologic outcome is associated with increased overall survival after esophagectomy.
Kulshrestha S; Bunn C; Patel PM; Sweigert PJ; Eguia E; Pawlik TM; Baker MS
Surgery; 2020 Nov; 168(5):953-961. PubMed ID: 32675034
[TBL] [Abstract][Full Text] [Related]
5. Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy?
Mann DR; Engelhardt KE; Gibney BC; Batten ME; Klipsch EC; Mukherjee R; Bostock IC
J Surg Res; 2024 Mar; 295():61-69. PubMed ID: 37992454
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
[TBL] [Abstract][Full Text] [Related]
7. Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma.
Raman V; Jawitz OK; Voigt SL; Yang CJ; Wang H; Harpole DH; D'Amico TA
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1626-1635.e1. PubMed ID: 31740115
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma.
Rodriguez-Quintero JH; Kamel MK; Jindani R; Elbahrawy M; Vimolratana M; Chudgar NP; Stiles BM
Ann Surg Oncol; 2024 Jan; 31(1):228-238. PubMed ID: 37884701
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma.
Worrell SG; Alicuben ET; Oh DS; Hagen JA; DeMeester SR
Ann Surg; 2018 Mar; 267(3):484-488. PubMed ID: 28151801
[TBL] [Abstract][Full Text] [Related]
11. Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma.
Sugawara K; Yamashita H; Uemura Y; Mitsui T; Yagi K; Nishida M; Aikou S; Mori K; Nomura S; Seto Y
Surgery; 2017 Oct; 162(4):846-856. PubMed ID: 28739092
[TBL] [Abstract][Full Text] [Related]
12. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
[TBL] [Abstract][Full Text] [Related]
13. Delayed esophagectomy for adenocarcinoma is associated with a negative impact on long-term survival and an increased risk of perioperative morbidity.
Huang VP; Ding L; Kim AW; Wightman SC; Atay SM
J Surg Oncol; 2024 Mar; 129(3):592-600. PubMed ID: 37986276
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.
Crabtree TD; Kosinski AS; Puri V; Burfeind W; Bharat A; Patterson GA; Hofstetter W; Meyers BF
Ann Thorac Surg; 2013 Aug; 96(2):382-90. PubMed ID: 23731608
[TBL] [Abstract][Full Text] [Related]
15. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
[TBL] [Abstract][Full Text] [Related]
16. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.
Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF
Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic factors associated with pathologic upstaging in patients clinically diagnosed stage T2N0M0 squamous cell esophageal carcinoma.
Li M; Xie H; Zhen F; Wang H; Peng Z; Xu L
J Cancer Res Ther; 2020 Sep; 16(5):1106-1111. PubMed ID: 33004755
[TBL] [Abstract][Full Text] [Related]
19. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study.
Marino KA; Sullivan JL; Weksler B
J Thorac Cardiovasc Surg; 2018 May; 155(5):2211-2218.e1. PubMed ID: 29455958
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation.
Coker AM; Barajas-Gamboa JS; Cheverie J; Jacobsen GR; Sandler BJ; Talamini MA; Bouvet M; Horgan S
J Laparoendosc Adv Surg Tech A; 2014 Feb; 24(2):89-94. PubMed ID: 24401141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
